PAPPA and leiomyoma: PAPP-A is another important first-trimester serum marker that can screen for both chromosomal anomalies and adverse obstetric outcomes; lower PAPP-A levels in women pregnant in the presence of large fibroids can potentially guide fibroid management to avoid these outcomes.